Journal for ImmunoTherapy of Cancer (Nov 2020)
201 Carboplatin, paclitaxel and pembrolizumab for the first line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)